Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.
Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe website has added a 'Show less' option, while several detailed fields related to participant groups, interventions, and study data formats have been removed.SummaryDifference3%
- Check17 days agoChange DetectedSeveral key health-related resources, including MedlinePlus and DailyMed links for specific cancer treatments, have been removed from the website.SummaryDifference0.4%
- Check24 days agoChange DetectedThe website has been updated to version 2.12.2, adding new links to genetic information and drug details, while removing the 'Show less' option and the previous revision note.SummaryDifference4%
- Check31 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.1%
- Check61 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.